A detailed history of First International Bank & Trust transactions in Abb Vie Inc. stock. As of the latest transaction made, First International Bank & Trust holds 1,809 shares of ABBV stock, worth $322,020. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,809
Previous 1,629 11.05%
Holding current value
$322,020
Previous $279,000 27.96%
% of portfolio
0.12%
Previous 0.1%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$163.84 - $199.33 $29,491 - $35,879
180 Added 11.05%
1,809 $357,000
Q2 2024

Jul 03, 2024

SELL
$154.79 - $180.76 $90,242 - $105,383
-583 Reduced 26.36%
1,629 $279,000
Q4 2023

Jan 09, 2024

SELL
$137.6 - $154.97 $197,456 - $222,381
-1,435 Reduced 39.35%
2,212 $342,000
Q3 2023

Oct 12, 2023

SELL
$133.59 - $154.65 $180,880 - $209,396
-1,354 Reduced 27.07%
3,647 $543,000
Q2 2023

Jul 17, 2023

BUY
$132.51 - $164.9 $7,288 - $9,069
55 Added 1.11%
5,001 $673,000
Q1 2023

Apr 14, 2023

BUY
$144.61 - $166.54 $6,362 - $7,327
44 Added 0.9%
4,946 $788,000
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $6,500 - $7,795
47 Added 0.97%
4,902 $792,000
Q3 2022

Nov 01, 2022

BUY
$134.21 - $153.93 $88,712 - $101,747
661 Added 15.76%
4,855 $651,000
Q2 2022

Aug 09, 2022

BUY
$137.62 - $174.96 $122,481 - $155,714
890 Added 26.94%
4,194 $643,000
Q1 2022

Apr 08, 2022

SELL
$131.98 - $163.75 $59,522 - $73,851
-451 Reduced 12.01%
3,304 $536,000
Q4 2021

Mar 29, 2022

BUY
$107.43 - $135.93 $403,399 - $510,417
3,755 New
3,755 $508,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First International Bank & Trust Portfolio

Follow First International Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First International Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on First International Bank & Trust with notifications on news.